Concepedia

Laura Agensky

LA

2

Publications

40

Citations

2

H-Index

2019

Active since

Affiliations

DNAtrix (United States)(Current)

University of California, Los Angeles

Cornell University

University of Minnesota

University Health Network

Laura Agensky is an author at DNAtrix (United States) specializing in molecular oncology, immunotherapy, and cancer therapeutics.

Top concepts

GliomaMedicineOncologyPathologyImmunologyImmunotherapyCancer TherapyNeuro-oncologyCancer ResearchHigh-grade Gliomas

Publications per year

2019–2020

2

Publications

2

LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)

Gelareh Zadeh, Mariza Daras, Timothy F. Cloughesy et al. · Neuro-Oncology · 2020 · 26 citations · Full text

Immunology, Cycle 31, Pathology +21

ATIM-33. INTERIM RESULTS OF A PHASE II MULTI-CENTER STUDY OF ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)

Robert Aiken, Clark Chen, Timothy F. Cloughesy et al. · Neuro-Oncology · 2019 · 14 citations · Full text

Phase Ii Open-label, Immunology, Pathology +20

Rows per page

1–2 of 2